SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
September 5, 2003
Date of Report (Date of earliest event reported):
SuperGen, Inc.
(Exact name of registrant as specified in its charter)
Delaware |
| 0-27628 |
| 91-1841574 |
(State or other |
| (Commission |
| (IRS Employer |
| ||||
4140 Dublin Blvd, Suite 200, Dublin, California |
| 94568 | ||
(Address of principal executive offices) |
| (Zip Code) | ||
| ||||
Registrant’s telephone number, including area code: (925) 560-0100 | ||||
Item 5. Other Events
On September 5, 2003, SuperGen, Inc. (the “Company”) issued a press release announcing that Dr. Joseph Rubinfeld, Co-Founder, Chairman & CEO of the Company, will, upon completion of his employment contract on December 31, 2003, retire and assume the post of Chairman Emeritus and continue as a member of the Board of Directors. The Company further announced that the Board of Directors voted to appoint Dr. James Manuso, currently a member of the Board of Directors, as Chairman and Chief Executive Officer effective January 1, 2004. In the interim transition period, Dr. Manuso will serve the Company as a full-time consultant.
A copy of the press release is filed as an exhibit to this report and is incorporated in this report by reference.
Item 7. Financial Statements and Exhibits.
(c) Exhibits
99.1 Press release dated September 5, 2003 announcing the future retirement and transition plan for Dr. Joseph Rubinfeld and appointment of James Manuso as Chairman-Elect and CEO-Elect
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| SUPERGEN, INC. | ||
| |||
| |||
Date: September 8, 2003 | By: | /s/ JOSEPH RUBINFELD |
|
| Joseph Rubinfeld, Ph.D. | ||
| Chief Executive Officer, President | ||
3
EXHIBIT INDEX
Exhibit No. |
| Description |
|
|
|
99.1 |
| Press release dated September 5, 2003 announcing the future retirement and transition plan for Dr. Joseph Rubinfeld and appointment of James Manuso as Chairman-Elect and CEO-Elect |
